Wockhardt LimitedNSE: WOCKPHARMA

Press Release Jan 27 2026

· Issued by Wockhardt Limited

Filed with NSE · · 3 pages · English

On 6ix: 6ix.com/news/press-release-jan-27-2026-9

Release

Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release Wockhardt s Fifth Novel Antibiotic, Foviscu® (WCK 4282), Matches Gold-Standard Meropenem in pivotal Phase 3 Trial as First-Line Therapies Fail Against Rising Resistance .

Wockhardt Limited on 6ix

Earlier from Wockhardt

Later from Wockhardt

All Wockhardt news releases